IBRX
ImmunityBio, Inc. Common Stock
$7.64
4.37%
+0.32
Notify me if price changes either direction
Buy IBRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
8.1B
Enterprise value
8.6B
Trailing PE
-20.092105865479
Forward PE
-57.787952
PEG Ratio
-0.064123742123868
Enterprise to EBITDA
-36.361
Enterprise to revenue
51.605
Price to book MRQ
-9.0207670982491
Price to sales TTM
46.793583
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
165.8M
EBITDA
-235298000
Diluted EPS TTM
-0.95
Total Cash (MRQ)
357.4M
Current ratio (MRQ)
5.721
Operating Cash Flow (TTM)
-281137984
IBRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
